Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53-mutant Ovarian Cancer.
Eimeriida
Labyrinthitis
PUBLIC HEALTH TRAINEESHIPS
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PUBLIC HEALTH TRAINEESHIPS
Biography
contributor
Principal Investigator
Overview
sponsor award id
A03AH001083
Time
start date
1994-07-01
end date
1995-06-30